Serum Effects Following Tissue Thromboplastin Infusion

Summary Tissue thromboplastin injected into the femoral vein of anesthetized rabbits produced intravascular clotting in the vessels through which the thromboplastin flowed. In the systemic arteries macroscopically visible clots were never observed. No trace of tissue thromboplastin could be demonstrated in blood drawn from the carotid artery following infusion of tissue thromboplastin into the femoral vein. The slight, transient enhancement of coagulation of the arterial blood following tissue thromboplastin infusion was caused by a serum effect. After intravenous injection of serum, enhanced activation of coagulation could be observed for a period of up to 2 hrs. It is concluded that tissue thromboplastin, intravenously injected, is removed from the blood during its passage from the femoral vein to the systemic arteries, probably in the capillaries of the lung. True hypercoagulability appears to be due to a serum effect or caused by partial activation of the intrinsic coagulation system. The levels of coagulation precursors in blood are of minor significance.

[1]  I. Szeto,et al.  Clearance of infused fibrin. , 1965, Federation proceedings.

[2]  O. Ratnoff,et al.  STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. , 1964, The Journal of laboratory and clinical medicine.

[3]  D. Hume,et al.  Lethality of Intravascular Injections of Spleen and Liver Cells , 1964, Annals of Surgery.

[4]  D. Skinner,et al.  A METHOD FOR MEASUREMENT OF PASSAGE OF TUMOR CELLS THROUGH THE ISOLATED PULMONARY CIRCULATION. , 1963, Annals of Surgery.

[5]  T. Spaet Studies on the In Vivo Behavior of Blood Coagulation Product I in Rats , 1962, Thrombosis and Haemostasis.

[6]  S WESSLER,et al.  Thrombosis in the presence of vascular stasis. , 1962, The American journal of medicine.

[7]  J. Lewis,et al.  Effects of intravenous tissue thromboplastin in dogs: development of an anticoagulant. , 1962, The Journal of laboratory and clinical medicine.

[8]  J. A. Spittell,et al.  Accelerated thromboplastin generation in acute arterial occulusion complicating arteriosclerosis obliterans. , 1961, Annals of internal medicine.

[9]  T. Astrup,et al.  Estimation of thromboplastin activation in plasma. , 1961, Scandinavian journal of clinical and laboratory investigation.

[10]  S. Milojevic,et al.  Changes in fibrinogen level after infusion of thrombin and thromboplastin. , 1960, The American journal of physiology.

[11]  T. Spaet,et al.  Clearance of Blood Coagulation Product I in Rabbits.∗ , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  S. Rapaport,et al.  Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. , 1959, The American journal of medicine.

[13]  J. Graham,et al.  Postoperative hypofibrinogenemia: diffuse intravascular thrombosis after fibrinogen administration. , 1957, The New England journal of medicine.

[14]  R. Hartmann,et al.  The effect of intravenous infusion of thromboplastin on "heparin tolerance". , 1951, The Journal of clinical investigation.

[15]  O. Ratnoff,et al.  Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material. , 1951, Bulletin of the Johns Hopkins Hospital.